Towards Healthcare
Middle East and Africa Biotechnology Market to Boom USD 125.91 Bn by 2034

Middle East and Africa Biotechnology Market Advances and Trends

According to forecasts, the Middle East and Africa biotechnology market will grow from USD 46.53 billion in 2024 to USD 125.91 billion by 2034, with an expected CAGR of 10.80%. Rising food security concerns are estimated to drive the growth of the market. South Africa led the global market owing to its advanced research infrastructure in the region.

Content

  • Last Updated: 07 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The Middle East and Africa Biotechnology market stands at USD 51.47 billion in 2025 and is expected to reach USD 125.91 billion by 2034, growing at a CAGR of 10.80% from 2024 to 2034.

South Africa is leading the Middle East and Africa Biotechnology Market share 25% due to the strong institutions for vaccine development, genomics, and agricultural biotechnology, fostering innovation and commercialization.

Key trends include the Hybrid & climate-resilient seeds, plant growth regulators, and adoption of inorganic growth strategies, among others.

Governments are implementing policies and funding programs to promote R&D, biotechnology parks, and local manufacturing

Federation of African Societies of Biochemistry and Molecular Biology (FASBMB), International Centre for Genetic Engineering and Biotechnology (ICGEB), Biopharma Middle East & Africa, clinicaltrials.gov, A3P Middle East, WHO, Association of Agricultural Research Institutions in the Near East and North Africa, JAMA, International Centre for Genetic Engineering and Biotechnology (ICGEB), GOV.UK
Any Questions